The relative contribution to development of hepatocellular carcinoma of the mouse equivalent to the human p53ser249 mutation, found in human hepatocellular carcinoma associated with aflatoxin (AFB1) exposure, is compared with other major risk factors in a transgenic mouse model. Transgenic p53ser246
Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo
โ Scribed by Li Yin; Nader Ghebranious; Subhendu Chakraborty; Christine E. Sheehan; Zoran Ilic; Stewart Sell
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 220 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
The effect of expression of the p53 gene, in the presence or absence of the p53ser246 mutation (p53*), on ploidization (image cytometry), proliferation (expression of proliferating cell nuclear antigen and radioactive thymidine histoautoradiography), and apoptosis (in situ detection of DNA fragments) is determined in hepatocytes of p53-null and p53*-transgenic mice. The mouse p53ser246 mutation is equivalent to the p53ser249 mutation found in human hepatomas associated with hepatitis B virus infection and aflatoxin exposure. The hepatocytes of heterozygous or homozygous p53-knockout mice (p53ุ/ุ; p53ุ/ุ), as well as knockout mice expressing one allele of p53ser246 (p53ุ/ุ, p53*; p53ุ/ุ, p53*), do not undergo normal polyploidization with aging and show an increase in the number of cycling (G 1 -, S-, and M-phase) cells. In addition, p53ser246-transgenic mice (p53ุ/ุ, p53*; p53ุ/ุ, p53*; and p53ุ/ุ, p53*) have a greatly increased number of hepatocytes in the G 1 phase. No differences in rates of apoptotic hepatocytes are found among any of the mouse groups studied, so the increased proliferation results in a hyperplasia manifested by a increased number of small periportal cells. We conclude that loss of p53 removes blocks in the cell cycle, leading to increased proliferation, whereas expression of the p53ser246 mutation stimulates G 0 to G 1 and/or M to G 1 transition of hepatocytes. Increased proliferation of hepatocytes, combined with no concomitant increase in apoptosis, may in part explain the enhanced development of hepatocellular carcinomas in p53-knockout and p53*-transgenic mice exposed to aflatoxin.
๐ SIMILAR VOLUMES
## Abstract Livers from wildโtype and p53โdeficient mice were analyzed for the expression of cellโcycle regulatory proteins in an attempt to determine the mechanism for the increased proliferation of liver cells in p53โdeficient mice associated with enhanced susceptibility to aflatoxinโinduced live
We analyzed the genomic structure and mRNA of the RB and p53 genes in four mouse lymphoid leukemia cell lines (DL-1, DL-5, DL-8, and DL-12). Although no gross structural alteration of the RB gene was observed in any cell line, abnormalities of RB mRNA were detected in at least two cell lines. RB mRN
In mouse mammary tumorigenesis, p53 mutations facilitate tumorigenesis in concert with other oncogenic alterations. Ionizing radiation enhances tumorigenesis in preneoplastic mammary outgrowth lines and induces p53-dependent apoptosis. We asked if normal p53 function modulates radiation-induced tumo
Mutation of the p53 gene is found in about one third of astrocytic brain tumors, and expansion of tumor cell clones containing mutant p53 has been implicated in astrocytic tumor progression. However, admixture of normal cells in astrocytic tumor specimens limits the power of traditional studies of t
## Abstract We studied the frequency and pattern of __p53__ mutations in 16 mouse skin primary squamous carcinomas induced by chemical carcinogens and their 19 matched metastases. The molecular changes were analyzed by polymerase chain reactionโsingleโstrand conformation polymorphism and subsequent